BRBR stock icon

BellRing Brands

65.61 USD
+0.18
0.28%
At close Oct 17, 4:00 PM EDT
After hours
64.28
-1.33
2.03%
1 day
0.28%
5 days
4.14%
1 month
10.10%
3 months
27.27%
6 months
20.78%
Year to date
20.01%
1 year
46.45%
5 years
297.64%
 

About: BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders, and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.

Employees: 380

0
Funds holding %
of 6,740 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

303% more call options, than puts

Call options by funds: $47.2M | Put options by funds: $11.7M

58% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 48

7% more funds holding

Funds holding: 416 [Q1] → 444 (+28) [Q2]

9% more repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 148

0.43% less ownership

Funds ownership: 95.19% [Q1] → 94.77% (-0.43%) [Q2]

4% less capital invested

Capital invested by funds: $7.36B [Q1] → $7.06B (-$294M) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$55
16%
downside
Avg. target
$65
1%
downside
High target
$75
14%
upside

9 analyst ratings

positive
78%
neutral
22%
negative
0%
Truist Securities
Bill Chappell
70% 1-year accuracy
14 / 20 met price target
9%downside
$60
Hold
Maintained
16 Oct 2024
B of A Securities
Bryan Spillane
72% 1-year accuracy
13 / 18 met price target
14%upside
$75
Buy
Maintained
15 Oct 2024
Barclays
Lauren Lieberman
64% 1-year accuracy
46 / 72 met price target
4%upside
$68
Overweight
Maintained
11 Oct 2024
JP Morgan
Kenneth Goldman
100% 1-year accuracy
2 / 2 met price target
2%downside
$64
Overweight
Maintained
7 Aug 2024
Needham
Matt McGinley
50% 1-year accuracy
14 / 28 met price target
1%upside
$66
Buy
Reiterated
7 Aug 2024

Financial journalist opinion

Based on 3 articles about BRBR published over the past 30 days

Charts implemented using Lightweight Charts™